StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 02 Jun 2022 09:00:03 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Truist Securities Reiterates Buy Rating, $718 Price Target on Regeneron Pharma (REGN) Despite Biogen's (BIIB) Byooviz Launch http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html for the full story. http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html Thu, 02 Jun 2022 09:00:03 -0500 BIIB BIIG REGN Truist Securities Reiterates Buy Rating, $718 Price Target on Regeneron Pharma (REGN) Despite Biogen's (BIIB) Byooviz Launch http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html for the full story. http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html Thu, 02 Jun 2022 09:00:03 -0500 BIIB BIIG REGN Truist Securities Reiterates Buy Rating, $718 Price Target on Regeneron Pharma (REGN) Despite Biogen's (BIIB) Byooviz Launch http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html for the full story. http://www.streetinsider.com/Analyst+Comments/Truist+Securities+Reiterates+Buy+Rating%2C+%24718+Price+Target+on+Regeneron+Pharma+%28REGN%29+Despite+Biogen%27s+%28BIIB%29+Byooviz+Launch/20165969.html Thu, 02 Jun 2022 09:00:03 -0500 BIIB BIIG REGN Some Alexion Pharma (ALXN) Takeover Talk Could Cool - Analyst http://www.streetinsider.com/Rumors/Some+Alexion+Pharma+%28ALXN%29+Takeover+Talk+Could+Cool+-+Analyst/17559994.html Visit StreetInsider.com at http://www.streetinsider.com/Rumors/Some+Alexion+Pharma+%28ALXN%29+Takeover+Talk+Could+Cool+-+Analyst/17559994.html for the full story. http://www.streetinsider.com/Rumors/Some+Alexion+Pharma+%28ALXN%29+Takeover+Talk+Could+Cool+-+Analyst/17559994.html Thu, 05 Nov 2020 09:36:35 -0500 ALXN BIIG Some Alexion Pharma (ALXN) Takeover Talk Could Cool - Analyst http://www.streetinsider.com/Rumors/Some+Alexion+Pharma+%28ALXN%29+Takeover+Talk+Could+Cool+-+Analyst/17559994.html Visit StreetInsider.com at http://www.streetinsider.com/Rumors/Some+Alexion+Pharma+%28ALXN%29+Takeover+Talk+Could+Cool+-+Analyst/17559994.html for the full story. http://www.streetinsider.com/Rumors/Some+Alexion+Pharma+%28ALXN%29+Takeover+Talk+Could+Cool+-+Analyst/17559994.html Thu, 05 Nov 2020 09:36:35 -0500 ALXN BIIG Forward Pharma (FWP) PT Raised at Leerink Partners After Documents Widen Advantage in Biogen (BIIB) Case http://www.streetinsider.com/Analyst+PT+Change/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html for the full story. http://www.streetinsider.com/Analyst+PT+Change/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Mon, 20 Apr 2015 06:22:03 -0500 BIIG FWP Forward Pharma (FWP) PT Raised at Leerink Partners After Documents Widen Advantage in Biogen (BIIB) Case http://www.streetinsider.com/Analyst+PT+Change/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html for the full story. http://www.streetinsider.com/Analyst+PT+Change/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Mon, 20 Apr 2015 06:22:03 -0500 BIIG FWP Forward Pharma (FWP) PT Raised at Leerink Partners After Documents Widen Advantage in Biogen (BIIB) Case http://www.streetinsider.com/Analyst+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html for the full story. http://www.streetinsider.com/Analyst+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Mon, 20 Apr 2015 06:22:03 -0500 BIIG FWP Forward Pharma (FWP) PT Raised at Leerink Partners After Documents Widen Advantage in Biogen (BIIB) Case http://www.streetinsider.com/Analyst+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html for the full story. http://www.streetinsider.com/Analyst+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Mon, 20 Apr 2015 06:22:03 -0500 BIIG FWP Forward Pharma (FWP) PT Raised at Leerink Partners After Documents Widen Advantage in Biogen (BIIB) Case http://www.streetinsider.com/Hot+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html for the full story. http://www.streetinsider.com/Hot+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Mon, 20 Apr 2015 06:22:03 -0500 BIIG FWP Forward Pharma (FWP) PT Raised at Leerink Partners After Documents Widen Advantage in Biogen (BIIB) Case http://www.streetinsider.com/Hot+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Visit StreetInsider.com at http://www.streetinsider.com/Hot+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html for the full story. http://www.streetinsider.com/Hot+Comments/Forward+Pharma+%28FWP%29+PT+Raised+at+Leerink+Partners+After+Documents+Widen+Advantage+in+Biogen+%28BIIB%29+Case/10469963.html Mon, 20 Apr 2015 06:22:03 -0500 BIIG FWP